Previous close | 28.85 |
Open | 28.85 |
Bid | 27.90 |
Ask | 28.20 |
Strike | 340.00 |
Expiry date | 2024-01-19 |
Day's range | 28.85 - 28.85 |
Contract range | N/A |
Volume | |
Open interest | 91 |
Investor Ben Graham -- mentor to the Oracle of Omaha himself, Warren Buffett -- was once quoted as saying: "The individual investor should act consistently as an investor and not as a speculator." Vertex Pharmaceuticals (NASDAQ: VRTX) is looking to change the way people live with rare diseases. With a focus on underserved areas of the rare disease drug market, the biotech has developed a cash-rich and profitable business.
Venture into October's investment landscape with our five experts, unveiling opportunities in an uneven market environment.
Amazon (NASDAQ: AMZN) has skyrocketed by close to 50% so far this year. On average, analysts surveyed by Refinitiv forecast that Amazon's earnings per share will grow at a whopping 79% annualized rate over the next five years. The tech giant's biggest growth opportunity comes from Amazon Web Services (AWS).